ZA952059B - Erythromycin derivatives their preparation process and their use as medicaments - Google Patents

Erythromycin derivatives their preparation process and their use as medicaments

Info

Publication number
ZA952059B
ZA952059B ZA952059A ZA952059A ZA952059B ZA 952059 B ZA952059 B ZA 952059B ZA 952059 A ZA952059 A ZA 952059A ZA 952059 A ZA952059 A ZA 952059A ZA 952059 B ZA952059 B ZA 952059B
Authority
ZA
South Africa
Prior art keywords
medicaments
preparation process
erythromycin derivatives
erythromycin
derivatives
Prior art date
Application number
ZA952059A
Other languages
English (en)
Inventor
Constantin Agouridas
Yannick Benedetti
Jean-Francois Chantot
Alexis Denis
Odile Le Martret
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA952059B publication Critical patent/ZA952059B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA952059A 1994-04-08 1995-03-13 Erythromycin derivatives their preparation process and their use as medicaments ZA952059B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (1)

Publication Number Publication Date
ZA952059B true ZA952059B (en) 1996-03-13

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952059A ZA952059B (en) 1994-04-08 1995-03-13 Erythromycin derivatives their preparation process and their use as medicaments

Country Status (49)

Country Link
US (2) US5656607A (is)
EP (1) EP0676409B1 (is)
JP (1) JP3000023B2 (is)
KR (1) KR100317148B1 (is)
CN (1) CN1059445C (is)
AP (1) AP587A (is)
AT (1) ATE234853T1 (is)
AU (1) AU684939B2 (is)
BG (1) BG61916B1 (is)
BR (1) BR9506147A (is)
CA (1) CA2164638C (is)
CO (1) CO4370097A1 (is)
CZ (1) CZ296005B6 (is)
DE (1) DE69529934T2 (is)
DK (1) DK0676409T3 (is)
DZ (1) DZ1869A1 (is)
EE (1) EE04498B1 (is)
ES (1) ES2189820T3 (is)
FI (1) FI111264B (is)
FR (1) FR2718450B1 (is)
GB (1) GB2288174A (is)
GE (1) GEP19991836B (is)
HR (1) HRP950217B1 (is)
HU (1) HU215396B (is)
IL (1) IL112954A (is)
IS (1) IS1865B (is)
JO (1) JO1850B1 (is)
LV (1) LV11182B (is)
MA (1) MA23501A1 (is)
MD (1) MD663G2 (is)
MY (1) MY114672A (is)
NO (1) NO308361B1 (is)
NZ (1) NZ284498A (is)
OA (1) OA10200A (is)
PE (1) PE2896A1 (is)
PL (1) PL180837B1 (is)
PT (1) PT676409E (is)
RO (1) RO115634B1 (is)
RU (1) RU2141965C1 (is)
SA (1) SA97170757A (is)
SI (1) SI0676409T1 (is)
SK (1) SK284079B6 (is)
SV (1) SV1995000018A (is)
TN (1) TNSN95026A1 (is)
TW (1) TW316908B (is)
UA (1) UA44705C2 (is)
WO (1) WO1995027720A1 (is)
YU (1) YU49221B (is)
ZA (1) ZA952059B (is)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
BR9708930A (pt) * 1996-05-07 1999-08-03 Abbott Lab Composto derivado de 3-descladinose-2,3-anidro-eritromicina ou um seu sal ou éster farmaceuticamente aceitável processo para a preparação do composto composição farmacêutica e processo de tratamento de infecções bacterianas
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
WO1998009978A1 (en) * 1996-09-04 1998-03-12 Abbott Laboratories 6-o-substituted ketolides having antibacterial activity
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6140479A (en) * 1997-03-24 2000-10-31 Taisho Pharmaceuticals Co., Ltd. Erythromycin a derivatives
AU6932098A (en) * 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
JP2000513026A (ja) * 1997-06-11 2000-10-03 ファイザー・プロダクツ・インク ９−オキシム エリスロマイシン誘導体
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
WO2000017218A1 (en) 1998-09-22 2000-03-30 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
TR200102129T2 (tr) 1998-12-10 2002-01-21 Pfizer Products Inc. Karbamat ve karbazat ketolid antibiyotikleri.
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
FR2789392B1 (fr) 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
KR100710605B1 (ko) * 1999-04-16 2007-04-24 코산 바이오사이언시즈, 인코포레이티드 매크롤라이드 항감염제
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
IL145976A0 (en) 1999-04-16 2002-07-25 Ortho Mcneil Pharm Inc Ketolide antibacterials
JP2003500414A (ja) * 1999-05-24 2003-01-07 ファイザー・プロダクツ・インク １３−メチルエリスロマイシン誘導体
US6756359B2 (en) 2001-07-03 2004-06-29 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
CN105039464A (zh) 2002-07-01 2015-11-11 阿基昂生命科学公司,以生物技术资源部的名义经营 用于生产葡糖胺和n-乙酰氨基葡糖的方法和物质
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
EP1618119A2 (en) * 2003-04-25 2006-01-25 Chiron Corporation Pyridyl substituted ketolide antibiotics
EP1618120A2 (en) * 2003-04-25 2006-01-25 Chiron Corporation Novel ketolide derivatives
WO2009055557A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US8796232B2 (en) 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
WO2011119604A1 (en) 2010-03-22 2011-09-29 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20180110181A (ko) 2010-09-10 2018-10-08 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
CN105163785A (zh) 2013-03-14 2015-12-16 森普拉制药公司 用于治疗呼吸道疾病的方法及其制剂
CA2907085A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
KR102363621B1 (ko) 2013-04-04 2022-02-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 매크롤라이드 그리고 그의 제조방법 및 용도
WO2016057798A1 (en) * 2014-10-08 2016-04-14 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
US10640528B2 (en) 2015-03-25 2020-05-05 President And Fellows Of Havard College Macrolides with modified desosamine sugars and uses thereof
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
US5656607A (en) 1997-08-12
JO1850B1 (en) 1995-12-27
PT676409E (pt) 2003-08-29
FR2718450B1 (fr) 1997-01-10
NZ284498A (en) 1997-07-27
RO115634B1 (ro) 2000-04-28
CN1059445C (zh) 2000-12-13
FI955913A (fi) 1995-12-08
ATE234853T1 (de) 2003-04-15
YU49221B (sh) 2004-11-25
AU2310795A (en) 1995-10-30
JPH07278177A (ja) 1995-10-24
RU2141965C1 (ru) 1999-11-27
CA2164638A1 (fr) 1995-10-19
JP3000023B2 (ja) 2000-01-17
YU21695A (sh) 1997-12-05
LV11182A (lv) 1996-04-20
ES2189820T3 (es) 2003-07-16
FI111264B (fi) 2003-06-30
SA97170757A (ar) 2005-12-03
FI955913A0 (fi) 1995-12-08
GB2288174A (en) 1995-10-11
WO1995027720A1 (fr) 1995-10-19
CZ322395A3 (en) 1996-08-14
NO308361B1 (no) 2000-09-04
TW316908B (is) 1997-10-01
BG100150A (bg) 1996-06-28
MA23501A1 (fr) 1995-12-31
MY114672A (en) 2002-12-31
MD663G2 (ro) 1997-07-31
LV11182B (en) 1997-04-20
EP0676409A1 (fr) 1995-10-11
EE04498B1 (et) 2005-06-15
HRP950217B1 (en) 2004-06-30
KR100317148B1 (ko) 2002-06-22
AP587A (en) 1997-04-29
SK154695A3 (en) 1996-10-02
HU215396B (hu) 1998-12-28
PE2896A1 (es) 1996-02-12
GB9506856D0 (en) 1995-05-24
DZ1869A1 (fr) 2002-02-17
MD663F1 (ro) 1997-01-31
SV1995000018A (es) 1997-10-24
IL112954A0 (en) 1995-06-29
CZ296005B6 (cs) 2005-12-14
DE69529934D1 (de) 2003-04-24
AU684939B2 (en) 1998-01-08
CA2164638C (fr) 2003-12-30
SI0676409T1 (en) 2003-06-30
AP9500743A0 (en) 1995-07-31
DK0676409T3 (da) 2003-06-23
IS1865B (is) 2003-05-02
NO954942L (no) 1996-02-07
PL180837B1 (pl) 2001-04-30
EE9500080A (et) 1996-12-16
UA44705C2 (uk) 2002-03-15
CN1126997A (zh) 1996-07-17
IL112954A (en) 2000-07-16
OA10200A (fr) 1996-12-18
PL311871A1 (en) 1996-03-18
IS4309A (is) 1995-11-17
HRP950217A2 (en) 1997-08-31
GEP19991836B (en) 1999-11-05
DE69529934T2 (de) 2003-09-04
CO4370097A1 (es) 1996-10-07
HUT73772A (en) 1996-09-30
EP0676409B1 (fr) 2003-03-19
HU9503505D0 (en) 1996-02-28
BR9506147A (pt) 1996-04-16
SK284079B6 (sk) 2004-09-08
TNSN95026A1 (fr) 1996-02-06
NO954942D0 (no) 1995-12-06
US5760233A (en) 1998-06-02
BG61916B1 (bg) 1998-09-30
FR2718450A1 (fr) 1995-10-13

Similar Documents

Publication Publication Date Title
ZA953501B (en) Erythromycin derivatives their preparation process and their use as medicaments
ZA952059B (en) Erythromycin derivatives their preparation process and their use as medicaments
AP9901556A0 (en) Sulpponamide derivatives process for their preparation and their use as medicaments
IL129315A0 (en) Oxadiazoles process for their preparation and their use as medicaments
AP9500712A0 (en) Tetracyclic derivatives, process of preparation and use
IL98472A0 (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
NZ239476A (en) 3-amidopyrazole derivatives; medicaments and preparation thereof
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
LTIP1713A (en) Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
IL125622A0 (en) Novel erythromycin derivatives method for preparing same and use thereof as drugs
CZ20011622A3 (cs) Nové deriváty erythromycinu, způsob jejich přípravy a jejich použití jako léčiv
IL133101A0 (en) New derivatives of erythromycin their preparation and their use as medicaments
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
CZ63895A3 (en) 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use
ZA988285B (en) 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles process for their preparation and their use for medicaments
AU3011095A (en) 2,3-bridged 1,4-dihydropyridines, processes for their preparation and their use as medicaments
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
HU9500466D0 (en) Fungicidal 2-imidazoline-5-one derivatives and process for their preparation
ZA933899B (en) Thienothiazine derivatives process for their preparation and their use
ZA9711101B (en) Derivatives of erythromycin their preparation process and their use as medicaments
AU3853597A (en) New derivatives of erythromycin, their preparation process and their use as medicaments
IL121407A0 (en) Substituted indanylidineacetylguanidines process for their preparation their use as medicaments or in diagnosis and medicaments containing them
ZA9711324B (en) Steroids substituted in position 11 their preparation process their use as medicaments and the pharmaceutical compounds containing them
ZA919186B (en) Erythromycin derivatives,their preparation process,the intermediates obtained and their use as medicaments
IL114333A0 (en) Pyrimidinyl- and triazinyl-oxy-and-thio-3-haloalkyl-propionic acid derivatives their preparation and use